HC Wainwright Weighs in on Foghorn Therapeutics Inc.’s Q3 2024 Earnings (NASDAQ:FHTX)
Foghorn Therapeutics Inc. (NASDAQ:FHTX – Free Report) – Investment analysts at HC Wainwright cut their Q3 2024 EPS estimates for shares of Foghorn Therapeutics in a research report issued on Tuesday, May 7th. HC Wainwright analyst A. Fein now anticipates that the company will earn ($0.66) per share for the quarter, down from their prior […]
More Stories
Vistry Group (LON:VTY) Trading Down 16.1% – What’s Next?
Vistry Group PLC (LON:VTY – Get Free Report)’s stock price was down 16.1% during mid-day trading on Tuesday . The...
Head-To-Head Analysis: Bath & Body Works (BBWI) versus Its Peers
Bath & Body Works (NYSE:BBWI – Get Free Report) is one of 27 publicly-traded companies in the “Retail stores, not...
Agilent Technologies (NYSE:A) Raised to Buy at StockNews.com
Agilent Technologies (NYSE:A – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy”...
StockNews.com Upgrades Workday (NASDAQ:WDAY) to Buy
Workday (NASDAQ:WDAY – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating...
Sienna Resources (CVE:SIE) Trading 16.7% Higher – Time to Buy?
Sienna Resources Inc. (CVE:SIE – Get Free Report) shares rose 16.7% on Tuesday . The company traded as high as...
CION Investment Co. (NYSE:CION) to Issue $0.05 Annual Dividend
CION Investment Co. (NYSE:CION – Get Free Report) announced an annual dividend on Monday, December 23rd,NASDAQ Dividends reports. Shareholders of...